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The importance of timing differentiation during limb muscle
development
Helge Amthor*†, Bodo Christ*, Miguel Weil‡ and Ketan Patel†§
Background: Skeletal muscle of trunk, limbs and tongue develops from a small
population of cells that originates from somites. Although promoters and
inhibitors of muscle differentiation have been isolated, nothing is known about
how the amplification of the muscle precursor pool is regulated; this
amplification provides muscle mass during development. Furthermore, little is
known about how cells accumulate in the pre-muscle masses in the limbs. We
investigated the role of bone morphogenetic proteins (BMPs) and Sonic
hedgehog (Shh) during proliferation, differentiation and positioning of muscle.
Results: The proliferation of muscle precursors in limbs was linked to Pax-3
expression. Ectoderm removal downregulated Pax-3 expression, arrested
proliferation and prematurely initiated muscle differentiation which exhausted the
muscle precursor pool and prevented further muscle growth. BMP-2, BMP-4
and BMP-7 had a dose-dependent effect on pre-myogenic cells: low
concentrations maintained a Pax-3-expressing proliferative population,
substituting for ectoderm-derived proliferative signals and delaying
differentiation, whereas high concentrations prevented muscle development,
probably by inducing apoptosis. In the limb, Shh upregulated Bmp-2 and Bmp-7
expression which delayed muscle differentiation, upregulated Pax-3, amplified
the muscle precursor population and stimulated excessive muscle growth. 
Conclusions: These data indicate that embryonic muscle growth requires
muscle differentiation to be delayed. Muscle differentiation may occur through a
default pathway after cells escape proliferative signals. Positioning of muscle is
regulated by high concentrations of BMPs, thus a single type of signalling
molecule can determine crucial steps in muscle development: when and where
to proliferate, and when and where to differentiate.
Background
An increase in skeletal muscle mass and many different
muscles were required to adapt paired appendages to ter-
restrial life during the evolution of tetrapods. Whereas fish
move their paired fins with muscle derived from extended
myotomes, a different mechanism is used by tetrapods
[1–3]. To generate the necessary amount and diversity of
limb muscle, tetrapods have recruited a few committed
but dividing myogenic precursor cells from the dermomy-
otome which migrate into the limb [4]. During limb devel-
opment, these muscle progenitors proliferate, differentiate
and are patterned according to cues from their new envi-
ronment [5,6]. These observations have raised two funda-
mental questions: how is muscle growth generally
controlled and how is muscle positioned correctly?
Myogenesis consists of three overlapping phases: determi-
nation, proliferation and differentiation [7]. Before any
myogenic determination has occurred, most cells of a pre-
streak epiblast-stage embryo possess myogenic compe-
tence, and when these cells are dispersed and grown in
culture they express muscle-specific proteins [8].
However, the muscle phenotype is only expressed in a
subset of cells which originate from somites, paraxial head
mesoderm and prechordal plate mesoderm relatively late
during development [9,10]. Grafting experiments have
established that cells of the dorsal half of the somite
become determined to a muscle fate approximately
6 hours after somite formation [9]. Further development of
somite-derived muscle is dependent on the position of the
precursors within the dorsal somite half. Cells from the
dorsomedial somite give rise to the epaxial muscle (intrin-
sic back muscle), whereas the hypaxial muscle (ventral
body, limb and tongue muscle) originates dorsolaterally
[11]. Additionally, epaxial and hypaxial muscle differ in
the time period between their determination and the onset
of differentiation; epaxial muscle cells start to differentiate
a few hours after determination, whereas hypaxial muscle
cells remain undifferentiated for over 2 days [12,13]. 
The onset of differentiation is dependent on extrinsic sig-
nalling from adjacent tissues [9]. Signals from the neural
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tube and notochord can induce muscle differentiation in
cells of the dorsomedial somite quarter, whereas signals
from the lateral plate prevent differentiation in the dorso-
lateral somite quarter [14–18]. Little is known about how
and why limb-muscle precursors are maintained for such a
long period in an undifferentiated state. A clue has
emerged recently from work by Pourquié et al.  [19] who
found that bone morphogenetic protein 4 (BMP-4) is
responsible for maintaining the undifferentiated state of
prospective hypaxial muscle and hence counteracts the
differentiation-inducing activity of the neural tube. When
limb mesenchyme is exposed to high levels of BMPs,
however, muscle cells are eliminated, probably by induc-
tion of apoptosis [20]. Limb muscle originates from cells
that have migrated as undifferentiated precursors from the
somites. These muscle precursor cells accumulate in
dorsal and ventral mesenchyme by stage 20 and form two
blocks that extend distally during limb outgrowth [21].
The mechanism by which myogenic cells are localised
into the dorsal and ventral limb mesenchyme has yet to be
determined, however.
We have investigated how a relatively small number of
determined myogenic cells are amplified to become a
large muscle mass and how muscle is positioned during
development. We show that surface ectoderm maintained
a population of proliferating undifferentiated muscle pre-
cursor cells (characterised by the expression of the tran-
scription factor Pax-3) in the underlying mesenchyme.
When ectoderm was removed, myogenic cells downregu-
lated Pax-3 expression and stopped proliferating. Ecto-
derm removal resulted in an upregulation of the gene
encoding the transcription factor MyoD (the first genetic
evidence of cells entering the myogenic programme) and
muscle began to differentiate. This prematurely depleted
the proliferative precursor reservoir and resulted in muscle
loss. BMPs ‘at low concentration’ could mimic ectoderm
activity, resulting in amplification of myogenic precursors
and in increased muscle mass. Our data suggest that the
muscle-promoting activity of the signaling molecule Sonic
hedgehog (Shh) is probably indirect and is mediated by
BMPs. Exposure to high concentrations of BMP may lead
to muscle loss. A dose-dependent response of myogenic
cells to BMP may spatially co-ordinate growth (through
proliferation) and positioning (through apoptosis). Differ-
entiation of muscle eventually occurs after cells escape the
influence of BMP signalling, through a default pathway.
Results
Spatial relationship of the expression domains of muscle
markers during limb development
Pax-3 expression has been proposed to be a marker for
undifferentiated myogenic cells and MyoD expression a
marker for differentiating muscle cells [7,22]. We exam-
ined the spatial distribution of transcripts of these genes
during wing development of chick embryos by in situ
hybridisation. Myogenic precursors that express Pax-3
accumulated as pre-muscle masses in the ventral and
dorsal limb mesenchyme by stage 20 (Figure 1a). The first
cells expressing MyoD were just detectable in the proximal
centre of the pre-muscle masses at this stage (Figure 1b).
By stage 22, the Pax-3 expression domain extended dis-
tally (Figure 1e), but did not extend in a central region that
correlated to the position of MyoD expression (Figure 1f).
Thus, myogenic cells are organised in a sequence of
expression domains during limb development, with undif-
ferentiated cells expressing Pax-3 situated anteriorly, pos-
teriorly and distally to the differentiating cells expressing
MyoD in the proximal centre of the pre-muscle masses
(Figure 1t). 
We examined transverse sections of the wing buds and
found that the pre-muscle masses were organised into a
subectodermal layer that expressed Pax-3 (Figure 1o) and
a layer of MyoD-expressing cells situated towards the mes-
enchymal core of the limb (Figure 1p). Therefore, myo-
genic cells are organised in a sequence of Pax-3 and MyoD
expression domains in all three limb axes. This spatial
relationship between Pax-3 and MyoD expression was
maintained during further limb outgrowth (Figure 1i,j) up
to stage 26–27, after which muscle cells were reorganised
during the process of muscle individualisation.
We examined the distribution of signalling molecules
that could be responsible for the spatial arrangement of
Pax-3 and MyoD. Pax-3-expressing cells were never
detected in the margins of the early limb (Figure 1a,e,i).
At stage 20, Bmp-2 was expressed in the posterior limb
margin and in the apical ectodermal ridge (AER;
Figure 1c). Bmp-4 was expressed in anterior, posterior and
distal limb margins and in the AER (Figure 1d). This
expression pattern was maintained during further limb
outgrowth (Figure 1g,h,k,l), except that by stage 25
Bmp-7 was expressed in distal wing tissue (Figure 1m).
Thus, cells expressing Bmp-2, Bmp-4 and Bmp-7 surround
the Pax-3 expression domain of the dorsal and ventral
pre-muscle masses (Figure 1t). Transverse sections of
stage 22 limbs revealed strong expression of Bmp-2 in
posterior mesenchyme and strong expression of Bmp-4 in
anterior mesenchyme; Bmp-4 was expressed less in poste-
rior mesenchyme (Figure 1q,r). Bmp-2 was expressed at
low levels in dorsal ectoderm and more prominently in
ventral ectoderm, as well as at low levels in dorsal and
ventral sub-ectodermal mesenchyme. Noggin, a gene
which encodes an antagonist of BMP [23], was expressed
in the mesenchymal core of the developing wing bud and
so was in close proximity to the MyoD-expressing cells
(Figure 1n,s). There was therefore an ordered array of
gene expression in the limb: Bmp-2 expression localised
to the ectoderm, Pax-3 expression in the sub-ectodermal
layer, MyoD in a deeper mesenchymal layer and Noggin in
a central core region (Figure 1t).
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These observations led us to ask the following questions.
Firstly, do tissues adjacent to Pax-3-expressing cells
maintain Pax-3 expression and do BMPs maintain this
Pax-3 expression? Secondly, do myogenic cells express
MyoD only after escaping the influence of signals that
maintain Pax-3 expression? And thirdly, what are the
consequences for muscle growth of prolonging the dura-
tion of Pax-3 expression by myogenic cells or of inducing
differentiation prematurely?
Limb-ectoderm-derived signals inhibit myogenesis by
maintaining cells in a proliferative state
To determine whether signals from the ectoderm are
important for the spatial organisation of cells expressing
Pax-3 and MyoD in the pre-muscle masses of the limb, we
removed dorsal wing ectoderm from embryos at stages
21–23 and monitored the effect on the expression of Pax-3
(n = 10) and MyoD (n = 8). A complete loss of Pax-3
expression in the dorsal pre-muscle mass was detected
20 hours after ectoderm removal (Figure 2a,c,d). This
shows that Pax-3 expression may depend on ectodermal
signals. We examined the fate of the myogenic cells after
ectoderm removal and, surprisingly, detected not only an
upregulation of MyoD but also an enlargement of the
MyoD expression domain after only 10 hours
(Figure 2b,e,f). Expression of Pax-3 has been suggested to
indicate that cells are in a proliferative state; we examined
this by labelling limb cells with bromodeoxyuridine
(BrdU) 17 hours after removing the ectoderm from stage
22–23 embryos (n = 2). Dorsal wing mesenchyme from
which the overlying ectoderm had been removed showed
almost no BrdU incorporation (Figure 2h) compared with
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Figure 1
Expression of Pax-3, MyoD, Bmp-2, Bmp-4,
Bmp-7 and Noggin in wing buds: dorsal view
of chick embryo whole-mounts. (a–d) Stage
20; (e–h) stage 22; (i–n) stage 25. (a,e,i)
Expression of Pax-3 transcripts revealed by in
situ hybridisation; (b,f,j) expression of MyoD;
(c,g,k) expression of Bmp-2; (d,h,l) expression
of Bmp-4; (m) expression of Bmp-7; (n)
expression of Noggin. (o–r) Stage 22
transverse sections from medial wing;
posterior (P) on left, anterior (A) on right,
dorsal (D) on top and ventral (V) on bottom.
(o) Pax-3 expression; (p) MyoD expression;
(q) Bmp-2 expression; (r) Bmp-4 expression.
(s) Stage 25 transverse section from medial
wing showing Noggin expression. (t) Diagram
summarising gene expression in a whole-
mount of an embryo at stage 25. The right-
hand panel shows a section of the whole-
mount taken at the position indicated by the
dotted line.
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the intact ventral side or unoperated contralateral wing
(Figure 2g). Thus, there is a strong correlation between
the expression of Pax-3 and the proliferation of muscle
precursors: the limb ectoderm maintains the pre-muscle
mass in a proliferative state and following its removal,
myogenic cells differentiate. 
We followed the late muscular phenotype 6 days after ecto-
derm removal (n = 9) and found that the MyoD expression
domain had not extended distally and the zeugopod and
autopod were free of MyoD expression (Figure 2i,j), but the
size of the residual proximal MyoD expression domain was
comparable to the size of MyoD expression domain seen
10 hours after ectoderm removal (Figure 2b,j). Examination
of the limb transverse sections (Figure 2j) after 6 days
revealed that dorsal tissue in both the autopod and zeugo-
pod were devoid of MyoD expression (data not shown).
Most MyoD expression was detected at the ‘elbow’ region.
In all limb ectoderm ablation experiments we left intact the
ectoderm overlying limb margins and the zone of polarising
activity (ZPA), which ensured further limb outgrowth and
normal proximo-distal and antero-posterior patterning of
the skeletal elements. The stylopod and zeugopod were
shortened in length in all cases examined, however
(Figure 2j). Serial sections revealed that the limb ectoderm
had not regenerated over the ablated regions (the prospec-
tive stylopod and zeugopod) even after 5 or 6 days re-incu-
bation, whereas the autopod was covered by ectoderm.
Expression of muscle actin showed that removal of ecto-
derm resulted not only in premature upregulation of MyoD
expression but also in the myogenic programme being
carried through to terminal differentiation. Expression of
muscle actin on the non-operated side was confined to a
thin deep layer (Figure 2k). On the operated side,
however, there was greater expression of muscle actin and
the expression domain extended more dorsally than in
non-operated limbs (Figure 2l). Desmin expression was
determined in limbs that were allowed to develop for
5 days after ectoderm removal at stage 22–23. Transverse
sections revealed a similar expression pattern to  that of
MyoD; the dorsal tissues in both the autopod and zeugo-
pod were devoid of desmin expression and desmin was
only detected in the dorsal region of the elbow (data not
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Figure 2
The influence of ectoderm on gene expression and cell proliferation in
the limb. The time after manipulation is indicated; the operated side is
on the right and the view is from dorsal side unless otherwise stated.
(a) In situ hybridisation with a Pax-3 probe after removal of the dorsal
wing ectoderm at stage 22. The arrow indicates the dorsal pre-
muscle mass. The shadow marks the expression in the ventral mass.
(b) MyoD expression after ectoderm removal at stage 23. The arrow
indicates upregulated expression and the size of the expression
domain is marked as 1 unit. (c) Pax-3 expression (arrow) in a
transverse section of the control limb from (a). (d) Pax-3 expression in
transverse section of limb from (a) after ectoderm removal.
(e) Transverse section of the embryo in (b) without ectodermal
removal showing expression of MyoD. (f) Transverse section of the
embryo in (b) after ectoderm removal showing MyoD expression
(arrow). (g) BrdU incorporation in a transverse section of a normal
stage 25 wing bud at medial level. (h) BrdU incorporation at stage 25
after dorsal ectoderm removal at stage 23 (extent of ectodermal
removal indicated by arrows). (i) Expression of MyoD in 6 day wing.
(j) Expression of MyoD in a 6 day wing after ectoderm removal at
stage 21; 1 unit corresponds to the unit in (b). (k) Normal expression
of muscle actin at a proximal region at stage 28. (l) Muscle actin
expression (domain indicated by the arrow) 36 h after dorsal
ectoderm removal at stage 24. (m) Pax-3 expression (arrow) after
grafting of dorsal zeugopod ectoderm of a stage 28 donor into the
wing mesenchyme of a stage 20 host. (n) MyoD expression (arrow)
after grafting of dorsal zeugopod ectoderm of a stage 28 donor into
the wing mesenchyme of a stage 20 host.
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(e) (f)
(g) (h)
(i) (j)
(k) (l)
(m) (n)
20 h 10 h
20 h 20 h
17 h 17 h
10 h 10 h
6 days 6 days1 unit
1 unit
36 h 36 h
26 h 26 h
Current Biology
shown). We next performed reciprocal experiments
whereby ectoderm from the dorsal wing zeugopod of a
stage 28 donor was grafted into the middle of the dorsal
wing mesenchyme of a stage 20 host and re-incubated for
26 hours (n = 4). In the presence of additional ectoderm,
the Pax-3 expression domain was expanded and wing
buds appeared larger (Figure 2m) whereas identical graft-
ing experiments showed reduced MyoD expression (n = 6)
compared with contralateral limb (Figure 2n). 
These results suggest that the ectoderm maintains a pool
of Pax-3-expressing proliferating muscle precursors from
which cells continually leave to form musculature of the
limb. Pax-3-expressing cells that do not receive the prolif-
erative signal spontaneously upregulate MyoD and enter
the differentiation programme. Ectoderm removal
exhausts the proliferative cell pool, and even though there
is an initial burst of muscle differentiation, subsequent
muscle growth is arrested due to a lack of precursors. Fur-
thermore, the proliferative state of myogenic precursors
seems to be linked to a migratory potential of these cells,
because loss of proliferative activity after ectoderm
removal prevented formation of distal muscle during
further limb outgrowth. 
BMP-2, BMP-4 and BMP-7 rescue Pax-3 expression after
ectoderm removal in the limb
In early limb buds, the close spatial relationship between
Bmp and Pax-3 expression suggested that BMPs could
maintain Pax-3 expression in the same way that BMP-4
regulates Pax-3 during early somite development [19]. To
determine whether BMPs affect Pax-3 expression in
limbs, we implanted beads soaked in low concentrations
of BMP-2 (1 µg/ml) into the wing mesenchyme of
embryos at stage 22 (n = 3). Pax-3 expression was upregu-
lated in both dorsal and ventral pre-muscle masses
16 hours after this procedure (Figure 3a). Transverse sec-
tions of such limbs showed high Pax-3 expression within
the region of pre-muscle mass but no ectopic expression in
other regions (data not shown). To determine how BMP-2
signalling is related to ectodermal signalling, we removed
dorsal wing ectoderm of stage 22–23 embryos and applied
beads soaked in BMP-2  into the dorsal wing mesenchyme
and re-incubated the operated embryos for 17 hours
(n = 7). BMP-2 was able to maintain Pax-3 expression in
the absence of ectoderm (Figure 3b, compare with
Figure 2a). Furthermore, the premature upregulation of
MyoD that normally follows ectoderm removal was not
seen after BMP-2 bead implant (Figure 3c, compare with
Figure 2b). Beads soaked in both BMP-4 (1 µg/ml; n = 8)
and BMP-7 (1–100 µg/ml; n = 23) could also maintain Pax-
3 expression and prevent the premature upregulation of
MyoD after ectoderm removal (data not shown). Another
member of the family to which BMPs belong, TGF-β1
(1 µg/ml–1 mg/ml), could not maintain Pax-3 expression
after ectoderm removal, however (data not shown). There-
fore, BMP-2, BMP-4 and BMP-7 induce and maintain
Pax-3 expression in the absence of ectoderm. Application
of beads soaked in BMP-2 at 10 µg/ml and higher concen-
trations inhibited both Pax-3 and MyoD expression,
whereas BMP-2 at 100 ng/ml or less gave an equivalent
effect to ectoderm removal alone (data not shown).
We tested whether ectoderm removal interferes with
Bmp-2 and Bmp-4 expression in the mesenchyme of limb
margins and in subectodermal mesenchyme (n = 5), but we
found no alteration in the expression of either gene at these
sites. Therefore BMP-2, BMP-4 and BMP-7 can upregu-
late Pax-3 after being applied to the limb or can maintain
Pax-3 expression in the absence of ectoderm. BMPs
expressed in the mesenchyme, however, are not able to
substitute for the ectoderm but may enhance ectodermal
proliferative action on myogenic cells. We found transcripts
of Noggin in the limb core, suggesting that Noggin protein
could antagonise the action of BMPs locally and induce
muscle differentiation. This would result in the sequential
distribution of Pax-3- and MyoD-expressing cells in all
three limb axes described in Figure 1.
BMPs determine positioning of pre-muscle masses in the
limb
High levels of BMPs have been implicated previously in
preventing muscle development, possibly through the
induction of apoptosis [20]. This is partly substantiated by
expression data presented in this study showing that pre-
muscle masses are positioned between the high levels of
BMP-2, BMP-4 and BMP-7 at the anterior, posterior and
distal limb margins. We implanted beads soaked in BMPs
at high concentrations into the wing-bud mesenchyme of
embryos at stages 21–22 and determined the effect on
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Figure 3
Effect of BMP-2 on limb-muscle development.
(a) Pax-3 expression (arrow) 16 h after
implantation of a bead soaked in BMP-2
(1 µg/ml) into the wing mesenchyme of an
embryo at stage 22. (b) Pax-3 expression
(arrow) and (c) MyoD expression (arrow) 17 h
after the BMP-2 bead was implanted following
dorsal ectoderm removal at stage 23.
(a) (b) (c)
16 h 17 h17 h
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expression of Pax-3 and MyoD (BMP-2, n = 12; BMP-4,
n = 21; BMP-7, n = 14). Whereas low concentrations of
BMP-2 (1 µg/ml) enhanced Pax-3 expression, BMP-2 at
higher levels (100 µg/ml) prevented expression of Pax-3
(Figure 4a) and MyoD (Figure 4b) close to the bead after
27 hours of re-incubation. Interestingly, we detected a
contour of high Pax-3 expression at some distance from the
bead (Figure 4a). Similarly, implantation of BMP-4 beads
(10 µg/ml) prevented expression of Pax-3 (Figure 4c) and
MyoD (Figure 4d) close to the bead, and again high Pax-3
expression was detected at some distance from the bead
(after 20 hours re-incubation). Finally, BMP-7 beads
(1 mg/ml) induced apoptosis after only 8 hours (Figure 4f),
and when the same wings were processed for in situ
hybridisation against Pax-3 transcripts we found a simulta-
neous downregulation of Pax-3 expression around the
bead (Figure 4e). The area of apoptosis appeared to be the
same as the area of Pax-3 loss. These effects were similar
after 24 hours and the zone of high Pax-3 expression bent
around the bead (data not shown). We were unable to
detect apoptosis at any time after implantation of beads
soaked in lower concentrations of BMP-7 (100 µg/ml; data
not shown). Beads soaked in either BMP-2 (100 µg/ml) or
BMP-4 (10 µg/ml) were able to induce apoptosis 24 hours
after being inserted into limbs from stage 21–22 embryos.
Histological examination (using Feulgen-stained wax sec-
tions and toluidine-blue-stained semi-thin sections) of
tissue architecture following implantation of beads soaked
in high concentrations of BMPs showed little signs of
necrosis (for example, cell debris or cellular aggregation).
There were normal spindle-shaped cells next to and on
the surface of the BMP-soaked beads, however. Histologi-
cal examination after implantation of beads soaked in
buffer (PBS) revealed no changes in tissue architecture
(data not shown).
To determine whether the effect induced by the BMPs
was specific to these proteins, we implanted beads soaked
in TGF-β1 (10 µg/ml), and found that although  expres-
sion of Pax-3 (Figure 4g) and MyoD (Figure 4h) was pre-
vented near the bead, there was no upregulation of Pax-3
further away. In the limb, however, inserting beads with
high concentrations of BMP might alter the migration of
muscle precursors. We therefore introduced BMP-2 beads
(100 µg/ml) into somites at thoracic level at stages 21–22,
at which stage Pax-3 and MyoD were expressed already,
and re-incubated them for 27 hours (n = 10). We found
that Pax-3-positive (Figure 4i) and MyoD-positive
(Figure 4j) cells were lost near the bead but, remarkably,
Pax-3 was upregulated some distance away as in the limb
(Figure 4i). Similarly, following BMP-7 bead insertion
(1 mg/ml) into thoracic somites of stage 21–22 embryos
(n = 13), Pax-3 (Figure 4k) and MyoD (Figure 4l) were lost
over several somites, but at the periphery Pax-3 was upreg-
ulated (after 25 hours of re-incubation). Implantation of
heparin beads soaked in PBS did not affect the expression
of either Pax-3 or MyoD or reveal any acridine orange stain-
ing (data not shown).
Thus, BMP at concentrations that were able to induce
apoptosis caused a simultaneous loss of Pax-3 and MyoD
expression; this indicates a loss of undifferentiated and
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Figure 4
A graded response to BMP signalling determines positioning of 
pre-muscle masses in the limb. Beads soaked in high doses of
(a,b) BMP-2 (100 µg/ml), (c,d) BMP-4 (10 µg/ml), (e,f) BMP-7
(1 mg/ml) and (g,h) TGF-β1 (10 µg/ml) were inserted into posterior
mesenchyme of the right wing and thoracic somites at stages 21–23.
The time after manipulation is indicated. Changes in (a,c,e,g) Pax-3
expression and (b,d,h) MyoD expression are indicated by arrows.
(f) Before in situ hybridisation, the same wing from (e) was incubated
in acridine orange which labelled apoptotic cells near the BMP-7 bead
(apoptotic cells appear as fluorescent dots; the bead is marked by red
dotted circle). Beads soaked in high concentrations of (i,j) BMP-2 and
(k,l) BMP-7 were inserted into thoracic somites. Changes in (i,k) Pax-3
expression and (j,l) MyoD expression are indicated by arrows.
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differentiated muscle cells. Pax-3 was upregulated at some
distance from BMP beads but not at this distance away
from TGF-β1 beads, however. These results suggest that
high BMP concentrations lead to muscle loss by induction
of apoptosis and low concentrations increase myogenic
proliferation. Thus, a dose-dependent response to BMP
spatially co-ordinates the positioning and growth of the
pre-muscle masses within the anterior–posterior and prox-
imal–distal limb axes.
Shh stimulates muscle growth in limbs via induction of
proliferative signals
Shh in zebrafish has been shown to amplify the number of
myogenic cells [24]. It is possible that such a response to
Shh could be achieved by the induction of a proliferative
signal. Indeed, it is known that Shh can induce Bmp
expression during limb development [25,26]. We there-
fore used the limb to examine the activity of Shh on
muscle in the presence of ectopically induced proliferative
signals. To show that Shh is able to induce Bmp in the
limb, we inserted beads soaked in Shh protein into the
centre of dorsal wing mesenchyme of embryos at stages
21–22 and hybridised with probes against Bmp-2 and
Bmp-7 transcripts (n = 5). Shh bead insertion for 24 hours
resulted in an upregulation of Bmp-2 expression and the
Bmp-2 expression domain was enlarged on the dorsal wing
surface (Figure 5g). We examined such a wing in trans-
verse section and detected an upregulation of Bmp-2 in
the dorsal ectoderm and subectodermal mesenchyme
(data not shown). Furthermore, in the presence of addi-
tional Shh, the distal Bmp-7 expression domain extended
anteriorly and a faint increase of expression at the dorsal
limb surface was detected (data not shown).
We then examined the effect of Shh on limb-muscle
development. We inserted beads soaked in Shh protein
into the centre of dorsal wing mesenchyme of embryos at
stages 20–24 and determined the effect on pre-muscle
masses by monitoring expression of Pax-3 (n = 16) and
MyoD (n = 15). After 24 hours, Pax-3 expression was dra-
matically upregulated in a wing from a stage 20 embryo,
and the size of the expression domain was enlarged
(Figure 5a). Transverse sections revealed that Pax-3
expression was confined to a sub-ectodermal layer (data
not shown). After an identical procedure, MyoD expression
was completely inhibited, however (Figure 5b). Insertion
of an Shh bead at later stages only partially prevented
MyoD expression (data not shown). These experiments
indicate that myogenic cells that were already expressing
MyoD at the time of bead insertion did not stop expressing
it, but the transition of cells from expressing Pax-3 to
expressing MyoD was prevented. Wing buds after exposure
to Shh appeared twice the size of non-operated limbs
(Figure 5a,b). The area over which Shh stimulated Pax-3
expression correlated with the area over which Patched
expression was upregulated (n = 3; Figure 5h). Intriguingly,
as early as 28 hours after Shh had been applied to stage 24
wings, cells of the enlarged pre-muscle masses differenti-
ated and MyoD expression was upregulated (Figure 5c),
although high levels of Pax-3 expression were still main-
tained. Transverse sections of limbs incubated with Shh
and hybridised with probes for Pax-3 and MyoD showed
that normal expression sites were enlarged in proportion
with the enlargement of the limb. Expression of Pax-3 and
MyoD was confined to the dorsal and ventral pre-muscle
masses and was never detected at ectopic sites (data not
shown). An enlarged MyoD-expression domain was still
detected 52 hours after Shh beads were applied to a stage
21 wing (Figure 5d). Therefore, in the limb, ectopic Shh
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Figure 5
Effect of ectopic Shh on limb muscle development. The time after
manipulation is indicated. Arrows show expression domains. An Shh
bead was implanted into the wing mesenchyme of an embryo at stage
20 and (a) Pax-3 expression or (b) MyoD expression was assessed.
(c) MyoD expression 28 h after Shh bead insertion at stage 24.
(d) MyoD expression 52 h after Shh bead insertion at stage 21. An
Shh bead was inserted into the wing mesenchyme after dorsal
ectoderm removal at stage 22 and (e) Pax-3 expression or (f) MyoD
expression was assessed. (g) An Shh bead was implanted into wing
mesenchyme at stage 22 and Bmp-2 expression assessed. (h) An Shh
bead was implanted into the wing mesenchyme and thoracic somites
at stage 22 and expression of Patched seen in both the limb (arrow)
and somites (arrowhead) after 25 h.
(a) (e)
(b) (f)
(c) (g)
(d) (h)
24 h 14 h
24 h 14 h
28 h
52 h
24 h
25 h
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upregulated proliferative signals, revealed by expression of
Bmp-2 and Bmp-7. Furthermore, Shh upregulated Pax-3,
delayed MyoD expression and, finally, accelerated muscle
growth. Thus, Shh and ectoderm have similar effects on
limb muscle; this suggests that Shh acts indirectly as a pro-
liferative signal, via pathways induced by the ectoderm and
mesenchyme. We therefore tested the effect of Shh on
limb muscle after ectoderm removal. 
We applied Shh beads to dorsal limb mesenchyme of
embryos at stages 22–23 after ectoderm removal and re-
incubated the operated embryos for 20 hours (n = 12).
After this procedure, Pax-3 expression was downregulated
(Figure 5e) and MyoD was upregulated dorsally
(Figure 5f), whereas ventrally, where the ectoderm was
intact, Pax-3 was upregulated and MyoD was downregu-
lated (data not shown). Patched expression was broadly
upregulated throughout the mesenchyme which clearly
indicated the efficacy of Shh in limbs lacking ectoderm
(data not shown). Beads soaked in PBS did not disrupt the
normal expression of Pax-3, MyoD, Bmp-2 or Patched. Thus
the effect of Shh in inducing Pax-3 was indirect and medi-
ated via the BMPs.
Discussion 
Examining the fate of an embryonic cell lineage in vivo and
its response to environmental cues is extremely complex,
especially when the founder cells are multi-potent and
when markers are not available for analysing the undiffer-
entiated and differentiated states of cells. In this study we
focused on limb-muscle development, which is an attrac-
tive system because the precursor cells are heterotopic in
origin and have a single differentiated fate [4]. These pre-
cursors apparently have limited developmental options:
they can either remain as undifferentiated muscle precur-
sors, differentiate or undergo apoptosis. Furthermore, spe-
cific markers exist for myogenic precursors (Pax-3 [22]) and
differentiating muscle cells (MyoD [7]). Using the chick
limb as an experimental system, we could examine how
extrinsic signals influence the fate of limb-muscle cells.
Inhibition of Pax-3 activates MyoD expression and stops
further muscle development
Ectoderm signals maintain Pax-3 expression in cells that
form a proliferating muscle-precursor pool. Muscle growth
is dependent upon maintaining a balance between undif-
ferentiated proliferative cells and differentiated cells.
Removal of ectoderm inhibits muscle growth by depriving
precursor cells of the proliferative signals and results in
premature differentiation. This exhausts the muscle-pre-
cursor pool, leading to eventual muscle loss. Therefore, to
understand how embryonic limb muscle mass is generated,
the question to address is not only how differentiation is
induced but also how muscle progenitors are maintained in
a proliferative state.
The correlation of Pax-3 expression with proliferation and of
MyoD expression with a post-mitotic state supports the view
that expression of Pax-3 and expression of MyoD are mutu-
ally exclusive, and suggests that muscle-mass generation is a
subdivided process of proliferation and differentiation.
During embryonic development, this subdivision is spatially
organised, with Pax-3-expressing cells situated near the
ectoderm and MyoD-expressing cells situated deeper in the
mesenchyme. Our finding that Pax-3 expression is linked to
proliferation is supported by the observation of Pax expres-
sion in human tumours. Furthermore, our results confirm
the view that members of the Pax family play an essential
role in determining the size and shape of whole organs [27].
Our experiments do not completely rule out, however, the
possibility that there are cells that can simultaneously prolif-
erate and express MyoD in the presence of ectoderm. Such
cells can only be ones that are in transition between the
Pax-3 layer and the MyoD layer, however, and therefore rep-
resent a very small portion of the total number of MyoD-pos-
itive cells. We demonstrated that premature differentiation
of limb muscle prevented distal elongation of the muscle
masses during further limb outgrowth. Thus, a source of
undifferentiated myogenic cells must be maintained so that
myogenic cells can migrate, because differentiating muscle
cells lose their migratory ability.
A graded response to BMPs spatially co-ordinates muscle
growth and position 
A striking feature of the early limb bud is the spatial
arrangement of Pax-3 and MyoD expression compared with
Bmp expression (Figure 1t). In all three limb axes, Bmp
expression domains do not overlap with Pax-3 expression,
but Pax-3-expressing cells accumulate preferentially at the
border of Bmp-expressing tissue. MyoD-expressing cells,
however, are not found in proximity to Bmp domains and
are situated deeper in the mesenchyme. We demonstrated
that BMP-2, BMP-4 and BMP-7 could be responsible for
this organisation. Low concentrations of BMPs maintained
Pax-3 expression after ectoderm removal and resulted in
muscle growth. None of the BMPs was as effective as the
ectoderm, however. This could be due to our use of homod-
imeric BMPs, which have been shown to have far lower sig-
nalling capacity than naturally occurring heterodimers
[28,29]. Mesenchymal BMPs and sub-ectodermal BMPs
were unable to maintain Pax-3 expression, suggesting that
these BMPs are in a different biochemical state from ecto-
dermal BMPs and BMPs introduced on beads. It is possible
that the ectoderm contains some BMP maturation factor(s).
In addition, other ectodermal proliferative signals, such as
Wnt proteins, could be acting on muscle [16,30,31]. It is not
possible for us to determine the physiological concentra-
tions of BMPs using our approach because homodimers are
unlikely to be the natural active agents.
In the presence of beads soaked in high concentration of
BMPs, myogenic cells were lost through apoptosis near to
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the source, but, remarkably, Pax-3-expressing cells accu-
mulated at some distance from the bead. This shows that
BMPs act as diffusible morphogens. A threshold response
of myogenic cells to different BMP concentrations could
divide the limb mesenchyme into three different zones:
one zone of high BMP activity, which myogenic cells
avoid or in which they die; a second zone of moderate
BMP activity, in which myogenic cells preferentially
accumulate and proliferate; and a third zone of low BMP
activity, which is not sufficient to maintain proliferation
and in which myogenic cells can differentiate. Thus, a
graded response to BMPs spatially co-ordinates growth
and positioning of muscle in all three axes of the limb.
Such a concentration-dependent activity of BMPs may
explain why, in different situations, BMPs could either
induce Pax-3 expression or induce a loss of all myogenic
cells [19,20]. 
The action of Noggin, a BMP antagonist that is expressed
in the mesenchymal core of the limb and thus adjacent to
MyoD expressing cells, could elaborate this BMP threshold
system by directly binding to, and inactivating, BMPs
[23]. Thus, a single family of signalling molecules, BMPs,
can regulate the crucial events during embryonic muscle
growth: when and where to proliferate, and when and
where to differentiate. We have also shown that BMP
upregulation following Shh application to the limb tran-
siently delays muscle differentiation and stimulates Pax-3
expression, eventually leading to unco-ordinated and
excessive muscle growth. We were able to rule out a direct
link between Shh and Pax-3 expression by applying Shh
to limbs after ectoderm removal; Shh did not have any
effect on Pax-3 expression. 
Is muscle differentiation a ‘default’ pathway?
Our results strongly indicate that any pathway which
downregulates Pax-3 expression forces myogenic cells to
express MyoD and thus to differentiate. Overexpression of
Pax-3 can, however, transform some but not all non-
muscle cell lines into a muscle lineage, suggesting that
Pax-3 can act as an activator of MyoD [30]. To resolve this
apparent contradiction, we have to take into account other
observations. Head muscle activates MyoD expression
without having expressed Pax-3 [32]. Likewise, dispersed
epiblast cells will express MyoD after a 4 hour culture
period although they have never expressed Pax-3 or the
muscle-determination factor Myf-5 [8]. Furthermore,
some MyoD-expressing cells have been detected in the
trunk of mice that have a mutated Pax-3 gene (Splotch
mutants) and also lack Myf-5, although in these mutants
almost all trunk, limb and tongue muscles are missing
[32]. Thus, muscle differentiation can occur indepen-
dently of Pax-3 activation.
We propose a model (Figure 6) that integrates all the
above findings and accommodates our suggestion that
muscle differentiation is initiated through a default
pathway. We suggest that a competence factor (Y), which
is a transcription factor, resides upstream of MyoD. When
factor Y is active, it can initiate MyoD expression (arrow
labelled 1 in Figure 6), but it also represses Pax-3 expres-
sion (2) and therefore stops proliferation and induces
muscle differentiation. BMPs and other proliferative (or
Pax-3-inducing) signals, such as Wnt [30,31], repress Y
expression (3) and so prevent premature muscle differen-
tiation. Repression of Y expression removes repression of
Pax-3 and activates proliferation (4). Shh induces BMP
(5), thereby activating proliferation. The repression of Y
by BMPs can be lifted by Noggin (6), leading to an upreg-
ulation of MyoD expression and initiation of differentiation
(7) and a repression of Pax-3 and proliferation. In our
model, however, the removal of repressing signals is suffi-
cient to upregulate Y and MyoD expression, and inducing
signals are not necessary to initiate differentiation in
determined myogenic cells. Pax-3 itself is upstream of Y
and can activate Y expression (8) which explains how pro-
liferative Pax-3-expressing myogenic cells can maintain
their determined state. The potential of Pax-3 to induce Y
expression and, subsequently, MyoD expression is seen
when cells are transfected with Pax-3, which results in
MyoD activation [30].
Conclusions
We have shown that continuous limb-muscle growth
requires the maintenance of myogenic proliferation and
the repression of muscle differentiation. Proliferation is
strongly linked to Pax-3 expression but is excluded by
MyoD expression and differentiation. BMPs act in a dose-
dependent manner, either as proliferative signals or to
prevent muscle development, restricting limb-muscle
growth to defined positions. Muscle differentiation can
occur merely after cells have escaped the influence of
proliferative signals, as shown by the effect of ectoderm
removal. Additionally BMP may upregulate Noggin, which
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Figure 6
How different signalling molecules could influence myogenic
proliferation (in green) and differentiation (in red) through regulation of
a competence factor (Y). See text for further details.
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encodes a BMP antagonist (H.A., B.C., K.P., unpublished
observations). Noggin might restrict the proliferative
action of BMPs, and thus promote differentiation. Our
results indicate that muscle differentiation is controlled
by regulating and modulating proliferative signals but can
be autonomously initiated through a default pathway.
BMPs and functionally related molecules might be able
to co-ordinate muscle growth in space and time. An
imbalance of BMPs and related factors alters the onset of
differentiation, and muscle growth is either arrested when
differentiation is prematurely initiated or is excessive
when differentiation is delayed.
Materials and methods 
Preparation of chick embryos
Fertilised chicken eggs were incubated at 38°C, and the embryos were
staged according to Hamburger and Hamilton [33]. Experiments were
performed on embryos at stage 20–24. The embryos were re-incu-
bated for 6 days, sacrificed, and processed for whole-mount in situ
hybridisation or antibody staining.
Bead implanting and microsurgical procedures
BMP-2 and BMP-4 were provided by Genetics Institute. Shh was a
gift from Andy McMahon. BMP-7 was obtained from ICRF. TGF-β1
was from R&D Systems. All proteins were applied to 80–120 µm
beads. Shh was applied to Affigel beads (Sigma) and BMP-2, BMP-4
and BMP-7 were applied to heparin acrylic beads (Sigma). Shh was
used at 14 mg/ml. BMPs were used at concentrations stated in text.
Proteins were loaded onto beads as described [34]. For bead
implant, the dorsal ectoderm and mesenchyme of the right wing or
somites were punctured with an electrolytically sharpened tungsten
needle, and a bead was inserted into the punctured mesenchyme
using a blunt glass needle. For ectoderm removal, the ectoderm was
stained with nile blue in ovo using a blunt glass needle coated with
2.5% agar containing 2% nile blue. The ectoderm was peeled from
the mesenchyme immediately after staining. At limb level, ectoderm
was removed only from the dorsal side, avoiding the limb margins,
apical ectodermal ridge and the ectoderm overlying the zone of polar-
ising activity. For ectoderm transplantation, stage 28 donor embryos
were sacrificed, transferred to DMEM medium (Sigma), the dorsal
half of the wing stylopod dissected and incubated in 2% trypsin/PBS
(Sigma) for 1 h at 4°C. Trypsinised limb pieces were transferred back
into medium and the ectoderm peeled from the mesenchyme. A small
slit was made into the dorsal ectoderm and mesenchyme of the right
wing of the host embryo (stage 20) in which a small piece of ecto-
derm was manipulated.
Histology assays
Acridine orange was used to determine apoptosis as the reagent has
been shown to be specifically intercalated by cells undergoing pro-
grammed cell death and not by those dying via necrosis [35]. Wing
buds were dissected free of all unwanted tissue and incubated in acri-
dine orange (100 ng/ml in PBS) at 37°C for 30 min. Specimens were
washed 2 × 2 min in PBS and flattened on a microscope slide under a
coverslip [36]. Samples were photographed immediately using fluores-
cence illumination and fixed for in situ hybridisation.
For whole-mount in situ hybridisation, all chick embryos were washed
in PBS and fixed overnight in 4% paraformaldehyde at 4°C. Antisense
RNA probes were labelled with either digoxigenin or fluorescein, and
whole-mount in situ hybridisation was performed as described [37].
The following probes were used in this study: Bmp-2, PCR-cloned
fragment (nucleotides 1–797); Bmp-4, PCR-cloned fragment
(nucleotides 1–953; gift from Paul Brickell); full-length Bmp-7 (1.1 kb;
gift from Antony Graham); full-length MyoD, clone CMD9 (1.5 kb; gift
from Bruce Patterson); full length Noggin (~700 bp; gift from Jonathan
Cooke); Patched, PCR-cloned fragment (900 bp; gift from Cliff Tabin);
Pax-3, 645 bp fragment corresponding to nucleotides 468–1113 (gift
from Martin Goulding). Whole-mount embryos were cryo-sectioned for
further histological examination.
For BrdU labelling, 30 min before fixation, 100 µl 40 mM BrdU (Sigma)
dissolved in water was added on the vitelline membrane and embryos
were re-incubated at 38°C. Embryos were fixed overnight in Serra solu-
tion (60% ethanol, 30% formaldehyde, 10% glacial acetic acid) at 4°C,
dehydrated, wax-embedded and sectioned. Antibody staining was pre-
ceded by hydrolysis for 30 min with 2 N HCl. Immunohistochemistry
was performed by indirect immunoperoxidase method with monoclonal
anti-BrdU antibody (DAKO) and peroxidase-conjugated goat anti-
mouse immunoglobulin (IgG; Sigma) as second antibody. Diaminoben-
zidine (DAB) was used as chromogen, and weak counter-staining was
performed with true red.
For immunohistochemistry, embryos were fixed in Serra solution, wax-
embedded and serially sectioned at 8 µm. Sections were labelled with
either a desmin monoclonal antibody (1:100; DAKO) or with a muscle-
specific actin monoclonal antibody (1:5000; Sigma). The secondary
antibody was a peroxidase-conjugated goat anti-mouse IgG antibody
(1:300; Sigma). DAB was used as a chromogen. For resin histology,
embryos were fixed in 0.12 M sodium cacodylate solution containing
3% glutaldehyde and 2% formaldehyde. They were embedded in epon
resin (Serva) according standard procedure and sections at 0.75 µm
using a Leitz-Ultra-Cut-S microtome. For Feulgen staining, wax-embed-
ded sections (8 µm) were stained according to standard procedure
(light green and Schiff′s Reagent).
Control experiments
We inserted beads soaked in either PBS only, BMP-2 at 100 ng/ml or
inactivated Shh. Ectoderm was either stained with nile blue but not
removed or peeled off, but positioned back on the mesenchyme. These
embryos were hybridised with probes against Pax-3 or MyoD; none of
the controls influenced the expression of either gene.
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